SGLT2 Inhibitors in the Management of Type 1 Diabetes (T1D): An Update on Current Evidence and Recommendations

Maffei P, Bettini S, Busetto L, Dassie F

Diabetes, Metabolic Syndrome and Obesity 2023, 16:3579-3598

Published Date: 9 November 2023